Tom Stitt (@tstitt) header
Tom Stitt (@tstitt) profile picture

Keeping busy.

Redwood City, CA, USA
Joined March 2007
Photo by Tom Stitt (@tstitt)Photo by Tom Stitt (@tstitt)Photo by Tom Stitt (@tstitt)Photo by Tom Stitt (@tstitt)Photo by Tom Stitt (@tstitt)Photo by Tom Stitt (@tstitt)Photo by Tom Stitt (@tstitt)Photo by Tom Stitt (@tstitt)
The hottest anyone has been in a movie I’ll start:
3,622
3,298
705
122,182
42,398,114
Alibrex: A New Blood Test to Reveal Whether a Cancer Treatment is Working lundberginstitute.org/?p=157…
275
The Case for Real-Time Cancer Therapy Monitoring - Rapid identification of late-stage cancer patients who are not responding to drug therapy. medium.com/@cadexgenomics/th…
1
3
Cadex Genomics provides real-time insight into therapy response for patients with stage IV solid tumors. “So far, Cadex’s technology is proving to be a game-changer for patients and their oncologists,” said Weiland. medcitynews.com/2019/04/the-… #cfDNA #cancertherapy
1
3
The doctor becomes the patient. greenvillejournal.com/2019/0…
1
1
Cadex Genomics has been selected as a finalist in the Diagnostics category for the Pitch Perfect Startup Contest at the MedCity INVEST Event April 23-24 in Chicago, IL. cadexgenomics.com/news/5b2b7…
1
1
Tom Stitt retweeted
.@CadexGenomics’ founders, Bill Haack, Sudhir Sinha, Gary Spitzer and Greg Schafer, are creating cutting-edge tests to track #cancer patients’ therapy response. Check out how this stellar #startup team is revolutionizing diagnostics! bit.ly/2HYJ8Hz
Great to see Bay Area member @CadexGenomics presenting their Alibrex technology at our #Biocompartnering conference.
3
4
Landmark #TAILORx results demonstrate that the #Oncotype DX test identifies the 70% of women with early-stage #breastcancer who receive no benefit from chemo. Watch this video to learn more about the trial: youtube.com/watch?v=iucCGlpA…
1
5
1
8
Liquid biopsies can accurately track lung cancer treatment responses by measuring ctDNA during immunotherapy and related treatments – 2 @HopkinsKimmel studies hopkinsmedicine.org/news/new… via @HopkinsMedNews
1
3
"There is a growing need to match mutational analysis assays with a mutation agnostic diagnostic assay that can more rapidly guide and inform cancer therapy for a wide range of patients" @skopetz #cancer #diagnostic goo.gl/zGefWE
2
2
"Video Of The Week: Is Crypto the Future of Early Stage Funding?" avc.com/2018/02/video-of-the… #2.1health #feedly
3 Reasons the Sun Went Down on #HCSM per @doctor_V 33charts.com/hcsm/
2
3
Last thoughts. The journey will continue - IOHT, AI, CRISPR, genetic therapies and more will all benefit from passionate people sharing informed views on social media. #hcsm
1
4
T3 Most significant change I've seen in health/social media is lots of VC-funded direct to patient/consumer services, labs, apps, care offers aimed at healthy people. The next change I hope to see is more focus on chronic disease mgmt. #hcsm
2
3